Pomerantz Law Firm Announces the Filing of a Class Action Against Regencell Bioscience Holdings Limited and Certain Officers – RGC

Pomerantz LLP filed a class action lawsuit against Regencell Bioscience Holdings Limited for alleged securities fraud. The lawsuit covers investors who purchased shares between October 28, 2024 and October 31, 2025. Regencell's stock experienced extreme volatility, surging to $78 per share in June 2025 before collapsing, with no corresponding business fundamentals. The company received a DOJ subpoena investigating trading in its ordinary shares, which triggered an 18.56% stock price decline upon disclosure.